Helius medical technologies, inc. (HSDT)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Mar'14
ASSETS
Current assets
Cash

4,360

5,459

9,019

14,311

18,656

25,583

12,397

15,987

4,395

5,562

2,617

6,859

-

2,669

-

-

-

-

-

-

-

-

Cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

7,666

-

6,172

7,973

2,643

4,350

192

971

418

15

Short-term investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

378

0

Accounts receivable, net

110

210

557

723

910

177

41

530

697

704

755

1,288

574

225

170

532

399

121

115

24

8

0

Other receivables

124

364

201

291

182

98

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory, net of reserve

594

598

1,289

902

731

392

197

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

190

349

340

556

-

-

997

-

-

-

-

-

Prepaid expenses

687

610

162

302

352

447

100

200

258

352

-

-

-

-

459

590

-

783

411

434

410

300

Other current assets

-

-

-

-

-

264

-

-

105

-

-

-

-

-

0

0

-

-

-

-

0

-

Total current assets

5,875

7,241

11,228

16,529

20,831

26,961

12,735

16,717

5,455

6,618

3,562

8,496

8,580

3,450

6,801

9,096

4,040

5,255

719

1,430

1,216

315

Property and equipment, net

678

712

725

711

693

554

558

350

190

173

174

115

-

0

-

-

-

-

-

-

-

-

Other assets
Goodwill

686

1,242

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

687

582

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use asset, net

517

552

586

619

650

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-current receivables

-

-

323

320

306

294

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

18

18

18

18

18

18

18

18

18

18

18

18

18

0

-

-

-

-

-

-

-

-

Total other assets

1,908

2,394

927

957

974

312

-

-

-

18

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL ASSETS

8,461

10,347

12,880

18,197

22,498

27,827

13,311

17,085

5,663

6,809

3,754

8,629

8,599

3,450

6,801

9,096

4,040

5,255

719

1,430

1,216

315

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable

1,111

1,676

1,714

3,047

2,474

2,392

2,186

1,521

2,573

3,479

3,637

3,826

-

2,161

-

-

-

-

-

-

-

-

Accrued liabilities

1,005

1,519

1,586

1,376

1,518

1,812

1,304

1,408

1,512

1,242

340

395

-

259

-

-

-

-

-

-

-

-

Operating lease liability

180

172

164

156

148

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

4,518

-

1,446

1,036

2,181

1,413

1,140

1,583

1,197

215

Shares to be issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

5,000

-

-

0

-

Shares to be issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

150

-

-

-

-

-

Derivative financial instruments

-

5

83

282

5,743

13,769

14,278

15,615

3,807

9,578

9,926

3,966

4,989

4,474

3,014

3,303

1,725

-

-

-

-

-

Deferred revenue

321

430

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation liability

-

-

-

-

-

-

-

10,594

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Promissory note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200

-

-

-

Deferred expense reimbursement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

120

-

-

-

Convertible debenture

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

368

Total current liabilities

2,617

3,802

3,547

4,861

9,883

17,973

17,768

29,138

7,892

14,299

13,903

8,187

9,508

6,894

4,461

4,340

4,056

6,413

1,461

1,583

1,197

583

Non-current liabilities
Operating lease liability

417

465

511

554

597

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

218

245

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

898

397

2,255

1,581

0

TOTAL LIABILITIES

3,252

4,512

4,058

5,415

10,480

17,973

17,768

29,138

7,892

14,299

13,903

8,187

9,508

6,894

4,461

4,340

4,056

7,311

1,859

3,838

2,779

583

Commitments and contingencies (Note 6)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

-

-

-

-

-

STOCKHOLDERS’ EQUITY
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Class A common stock, $0.001 par value; 150,000,000 shares authorized; 38,041,666 and 30,718,554 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

38

31

26

26

26

26

23

70,512

59,229

52,230

45,917

45,086

38,844

30,897

30,897

30,569

24,347

20,125

18,576

18,296

16,358

8,510

Additional paid-in capital

114,967

111,479

108,997

107,437

106,363

105,411

86,280

3,582

6,982

6,602

6,386

6,136

6,001

5,732

-

-

2,940

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,085

4,669

-

2,155

1,823

2,053

2,434

807

Shares to be issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

39

0

Accumulated other comprehensive loss

-266

-902

-759

-827

-703

-591

-883

-787

-906

47

188

-1,078

-1,732

-1,728

-1,265

-1,092

-999

-1,862

-1,498

-931

-971

0

Accumulated deficit

-109,530

-104,773

-99,442

-93,854

-93,668

-94,992

-89,877

-85,360

-67,534

-66,369

-62,640

-49,702

-44,022

-38,345

-32,376

-29,389

-26,305

-22,474

-20,042

-21,827

-19,423

-9,585

TOTAL STOCKHOLDERS’ EQUITY

5,209

5,835

8,822

12,782

12,018

9,854

-4,457

-12,053

-2,229

-7,490

-10,149

442

-908

-3,444

2,340

4,756

-16

-2,056

-1,140

-2,408

-1,562

-267

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

8,461

10,347

12,880

18,197

22,498

27,827

13,311

17,085

5,663

6,809

3,754

8,629

8,599

3,450

6,801

9,096

4,040

5,255

719

1,430

1,216

315